As the year draws to a close, Optoseeker Biotech has delivered an impressive performance for 2025, completing the installation and delivery of 22 proprietary high-end instruments. Covering three core technologies—structured light projection, digital microfluidics, and optoelectronic microfluidics—these solutions serve leading research institutes, universities, and biopharmaceutical companies globally. This milestone signifies that Optoseeker Biotech’s self-controllable high-end instrument solutions have gained widespread international recognition, marking a solid step forward in both domestic substitution and global expansion.

Recently, the National High-tech Enterprise Certification Management Office officially announced the latest list of recognized enterprises. Optoseeker Biotech has successfully earned the prestigious "National High-Tech Enterprise" designation. This certification is a testament to the company’s core technological breakthroughs in high-end life science instruments, its continuous R&D innovation, and its robust market potential. This national-level recognition serves as an authoritative endorsement of the company’s R&D capabilities and achievements in technology transfer. It marks a decisive step forward for Optoseeker Biotech in the localization of high-end life science instruments, officially elevating the company into the ranks of national high-tech leaders.

OptoSeeker Biotech is proud to announce that it has officially joined NVIDIA Inception, a global program designed to nurture startups that are reinventing industries with cutting-edge technology.

OptoSeeker Biotech, a pioneer in advanced life science instrumentation, today announced its inclusion in the prestigious "2025 Venture 50" China Life Sciences List. Released jointly by Zero2IPO Group and ChinaVenture, the list recognizes OptoSeeker for its robust technological capabilities and exceptional commercial potential, selecting the company from a competitive pool of tens of thousands of enterprises nationwide.

Recently, breakthrough research enabled by OptoSeeker Biotech’s flagship product, the OptoBot®500 Optoelectronic Tweezer System, was published in Laser & Photonics Reviews, an internationally renowned journal in laser science and photonics. The study, titled “Tuning Self-Assembled Topological Dipoles in Optoelectronic Traps,” highlights a major advancement in light-controlled topological self-assembly.

This publication marks the first time OptoSeeker Biotech’s DropletBot® Digital Microfluidic Platform has supported researchers in reaching JACS, underscoring the system’s innovation and international recognition in next-generation biomolecular detection.